Exagen Inc. Common Stock (XGN) is a publicly traded Healthcare sector company. As of October 13, 2026, XGN trades at $8.22 with a market cap of $203.98M and a P/E ratio of -10.43. XGN moved -0.36% today. Year to date, XGN is +35.69%; over the trailing twelve months it is -24.66%. Its 52-week range spans $2.59 to $12.23. Analyst consensus is strong buy with an average price target of $10.20. Rallies surfaces XGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for XGN, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $8.22 |
| Market Cap | $203.98M |
| P/E Ratio | -10.43 |
| EPS | $-0.81 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $2.59 |
| Volume | 1.05K |
| Avg Volume | 0 |
| Revenue (TTM) | $71.12M |
| Net Income | $-18.92M |
| Gross Margin | 58.64% |
5 analysts cover XGN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.20.